Iovance Biotherapeutics Inc
NASDAQ: IOVA
$7.39
-$0.34 (-4.4%)
Closing Price on July 3, 2024
IOVA Chart and Intraday Price
IOVA Company Data
| Asset Type | Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| Address | 999 SKYWAY ROAD, SUITE 150, SAN CARLOS, CA, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 4,683.27M USD |
| Shares Outstanding | 278,932,000 |
IOVA Articles
Public offerings of stock tempted some insider buying, and one insider stepped up to support a struggling online delivery service provider.
Published:
One of Cathie Wood's ARK Invest funds sold over 300,000 shares of cancer-focused biopharma startup Iovance Bio on August 26.
Published:
One of Cathie Wood's ARK Invest funds bought over 125,000 shares of Iovance Bio on August 25.
Published:
A couple of Cathie Wood's Ark Invest funds bought over 1 million shares of Iovance Bio on May 20.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including LendingTree, Merck, Micron Technology, Nvidia and Target.
Published:
These 10 stocks have incredibly strong stock charts and strong performance despite the crummy market conditions that have been seen so far in 2020.
Published: